[Chemotherapy of bronchial neoplasms]

Isospin asymmetry in the pseudospin dynamical symmetry.

Physical review letters·2001

Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis.

Toxicology·2001

Intra-arterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal: an active treatment modality with curative potential.

British journal of cancer·2000

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).

Annals of oncology : official journal of the European Society for Medical Oncology·2000

Phase II trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer. Groupe d'Oncologie Thoracique des Régions Alpines.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000

High dose etretinate and interferon-alpha--a phase I study in squamous cell carcinomas and transitional cell carcinomas.

Acta oncologica (Stockholm, Sweden)·1999

[A case of laryngocele with laryngeal carcinoma].

Nowotwory·1990

[Technique for postoperative irradiation of patients with breast cancer using electron and cobalt beams].

Nowotwory·1990

[Evaluation of results in radical treatment of breast cancer in men].

Nowotwory·1990

[Survival of patients with anaplastic cerebral gliomas treated with a combination of surgery and radiotherapy].

Nowotwory·1990

[Five year survival rate in patients with malignant neoplasms treated for the first time in the Oncology Center, M. Sklodowska-Curie Institute, Cracow Branch in the years 1979-1981].

Nowotwory·1990

[Selected aspects of diagnosis and treatment of prostatic cancer].

Nowotwory·1990

Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes.

Pharmacological research·2026

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.

Translational oncology·2026

A synergistic cascade nanoreactor breaks bladder cancer chemoresistance: Synergizing cholesterol metabolism reprogramming with cGAS-STING-mediated metallotherapy.

Materials today. Bio·2026

Motivations, Decision-Making, and Barriers to Treatment Innovation Adoption: A Mixed-Methods Study of Addiction Treatment Executives.

Research square·2026

Mitochondrial Dysfunction in Ifosfamide-Induced Nephrotoxicity: Mechanisms and Possible Interventions.

European journal of pharmacology·2026

A direct comparison of butyrate, 4-phenylbutyrate, and β-hydroxybutyrate in an in vitro tumor therapy model.

Cancer treatment and research communications·2026

Related Experiment Videos

[Chemotherapy of bronchial neoplasms]

Related Concept Videos

Isospin asymmetry in the pseudospin dynamical symmetry.

Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis.

Intra-arterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal: an active treatment modality with curative potential.

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).

Phase II trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer. Groupe d'Oncologie Thoracique des Régions Alpines.

High dose etretinate and interferon-alpha--a phase I study in squamous cell carcinomas and transitional cell carcinomas.

[A case of laryngocele with laryngeal carcinoma].

[Technique for postoperative irradiation of patients with breast cancer using electron and cobalt beams].

[Evaluation of results in radical treatment of breast cancer in men].

[Survival of patients with anaplastic cerebral gliomas treated with a combination of surgery and radiotherapy].

[Five year survival rate in patients with malignant neoplasms treated for the first time in the Oncology Center, M. Sklodowska-Curie Institute, Cracow Branch in the years 1979-1981].

[Selected aspects of diagnosis and treatment of prostatic cancer].

Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes.

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.

A synergistic cascade nanoreactor breaks bladder cancer chemoresistance: Synergizing cholesterol metabolism reprogramming with cGAS-STING-mediated metallotherapy.

Motivations, Decision-Making, and Barriers to Treatment Innovation Adoption: A Mixed-Methods Study of Addiction Treatment Executives.

Mitochondrial Dysfunction in Ifosfamide-Induced Nephrotoxicity: Mechanisms and Possible Interventions.

A direct comparison of butyrate, 4-phenylbutyrate, and β-hydroxybutyrate in an in vitro tumor therapy model.

Related Experiment Videos

[Chemotherapy of bronchial neoplasms]

Related Concept Videos

Related Articles